Compartir
Therapeutic Treatment for Benign Prostatic Hyperplasia (en Inglés)
Kirby, Roger S. ; Mcconnell, John D. ; Fitzpatrick, John (Autor)
·
CRC Press
· Tapa Dura
Therapeutic Treatment for Benign Prostatic Hyperplasia (en Inglés) - Kirby, Roger S. ; McConnell, John D. ; Fitzpatrick, John
$ 229.48
$ 382.46
Ahorras: $ 152.98
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Viernes 28 de Junio y el
Miércoles 10 de Julio.
Lo recibirás en cualquier lugar de Estados Unidos entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Therapeutic Treatment for Benign Prostatic Hyperplasia (en Inglés)"
The spectrum of available treatment options for benign prostatic hyperplasia (BPH) is matched by the spectrum of disease severity, and with up to 90% of men in their 80s suffering from BPH to some extent, it is imperative that patients are offered the full range of options to manage the disease. Pharmacologic therapies available for the treatment of lower urinary tract symptoms secondary to BPH include alpha-adrenoceptor antagonists, such as terazosin, doxazosin, alfuzosin and tamsulosin, and the 5-alpha-reductase inhibitors, finasteride and dutasteride. Other strategies, such as plant-derived medication or watchful waiting, are applied to varying extents. Derived from the benchmark title on BPH - Textbook of Benign Prostatic Hyperplasia - this well written and highly illustrated guide covers all these therapies and presents physicians with all they need to know to successfully manage the disease.
